Mustang Bio (MBIO) Competitors $0.17 +0.00 (+2.97%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MBIO vs. OKYO, AFMD, ANEB, VRCA, OTLK, SRZN, IXHL, RAPT, RNXT, and PMNShould you be buying Mustang Bio stock or one of its competitors? The main competitors of Mustang Bio include OKYO Pharma (OKYO), Affimed (AFMD), Anebulo Pharmaceuticals (ANEB), Verrica Pharmaceuticals (VRCA), Outlook Therapeutics (OTLK), Surrozen (SRZN), Incannex Healthcare (IXHL), RAPT Therapeutics (RAPT), RenovoRx (RNXT), and ProMIS Neurosciences (PMN). These companies are all part of the "pharmaceutical products" industry. Mustang Bio vs. OKYO Pharma Affimed Anebulo Pharmaceuticals Verrica Pharmaceuticals Outlook Therapeutics Surrozen Incannex Healthcare RAPT Therapeutics RenovoRx ProMIS Neurosciences OKYO Pharma (NASDAQ:OKYO) and Mustang Bio (NASDAQ:MBIO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability. Does the MarketBeat Community prefer OKYO or MBIO? Mustang Bio received 161 more outperform votes than OKYO Pharma when rated by MarketBeat users. However, 100.00% of users gave OKYO Pharma an outperform vote while only 64.26% of users gave Mustang Bio an outperform vote. CompanyUnderperformOutperformOKYO PharmaOutperform Votes8100.00% Underperform VotesNo VotesMustang BioOutperform Votes16964.26% Underperform Votes9435.74% Which has better earnings and valuation, OKYO or MBIO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOKYO PharmaN/AN/A-$16.83MN/AN/AMustang BioN/AN/A-$51.60M-$1.56-0.11 Do institutionals & insiders have more ownership in OKYO or MBIO? 3.0% of OKYO Pharma shares are held by institutional investors. Comparatively, 9.9% of Mustang Bio shares are held by institutional investors. 40.5% of OKYO Pharma shares are held by insiders. Comparatively, 0.6% of Mustang Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is OKYO or MBIO more profitable? OKYO Pharma's return on equity of 0.00% beat Mustang Bio's return on equity.Company Net Margins Return on Equity Return on Assets OKYO PharmaN/A N/A N/A Mustang Bio N/A -1,243.22%-172.89% Which has more risk and volatility, OKYO or MBIO? OKYO Pharma has a beta of -0.19, meaning that its share price is 119% less volatile than the S&P 500. Comparatively, Mustang Bio has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Do analysts recommend OKYO or MBIO? OKYO Pharma currently has a consensus price target of $7.00, indicating a potential upside of 560.38%. Mustang Bio has a consensus price target of $2.00, indicating a potential upside of 1,076.47%. Given Mustang Bio's higher possible upside, analysts plainly believe Mustang Bio is more favorable than OKYO Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Mustang Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor OKYO or MBIO? In the previous week, OKYO Pharma's average media sentiment score of 0.00 equaled Mustang Bio'saverage media sentiment score. Company Overall Sentiment OKYO Pharma Neutral Mustang Bio Neutral SummaryOKYO Pharma beats Mustang Bio on 5 of the 9 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBIO vs. The Competition Export to ExcelMetricMustang BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.12M$6.57B$5.13B$9.08BDividend YieldN/A2.99%4.91%4.22%P/E Ratio-0.1110.5591.4117.18Price / SalesN/A195.351,113.72116.79Price / CashN/A57.1642.7137.86Price / Book17.005.104.794.78Net Income-$51.60M$151.51M$120.07M$225.60M7 Day Performance-12.05%-2.14%-1.92%-1.23%1 Month Performance-18.23%-3.13%11.46%3.36%1 Year Performance-86.29%11.53%30.49%16.59% Mustang Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBIOMustang Bio1.9629 of 5 stars$0.17+3.0%$2.00+1,076.5%-87.1%$8.12MN/A-0.11100Positive NewsOKYOOKYO Pharma1.5637 of 5 stars$1.02-3.8%$7.00+586.3%-39.1%$34.52MN/A0.007AFMDAffimed4.4532 of 5 stars$2.14-0.5%$13.50+530.8%-68.5%$34.45M$8.95M0.0076Analyst RevisionNews CoverageANEBAnebulo Pharmaceuticals1.9457 of 5 stars$1.30-7.1%$8.00+515.4%-52.9%$33.71MN/A-4.674News CoverageGap UpVRCAVerrica Pharmaceuticals4.6573 of 5 stars$0.74-3.1%$9.50+1,188.7%-87.7%$33.62M$5.12M-0.4240Analyst ForecastNews CoverageOTLKOutlook Therapeutics1.8314 of 5 stars$1.42-4.1%$42.34+2,881.9%-82.8%$33.60MN/A0.0020SRZNSurrozen1.0933 of 5 stars$10.13+2.8%N/A+32.3%$32.92M$10M0.0042IXHLIncannex HealthcareN/A$1.86+5.1%N/A-54.1%$32.82M$86,000.00-1.343RAPTRAPT Therapeutics4.5178 of 5 stars$0.92+1.1%$9.50+932.5%-96.1%$32.17M$1.53M-0.3380RNXTRenovoRx1.2443 of 5 stars$1.25-2.4%$6.50+420.5%+76.1%$29.97MN/A-2.256Positive NewsGap UpPMNProMIS Neurosciences1.0765 of 5 stars$0.91-2.1%N/A-20.2%$29.75M$10,000.00-9.306Positive News Related Companies and Tools Related Companies OKYO Alternatives AFMD Alternatives ANEB Alternatives VRCA Alternatives OTLK Alternatives SRZN Alternatives IXHL Alternatives RAPT Alternatives RNXT Alternatives PMN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MBIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBIO Stock Alerts